Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Chronic osteomyelitis and sinus tract

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Sepsis, pathological fracture and malignant sinus change require escalation

A quiet draining sinus can abruptly close over an abscess, seed the bloodstream, destabilise weakened bone or develop squamous malignancy; apparent chronicity does not make acute deterioration safe.

Action: Assess physiology and limb perfusion, obtain blood cultures and give immediate parenteral antibiotics if septic, immobilise a threatened or fractured segment, urgently investigate new bleeding, fungation or rapid sinus change, and involve the bone-infection multidisciplinary team before unplanned antibiotics or limited surgery in a stable patient.

Synopsis

Understand persistent bone infection as a combined microbiological, dead-space, stability and soft-tissue problem, protect diagnostic yield, identify malignant change, and plan durable multidisciplinary eradication or suppression.

  • Chronic osteomyelitis is an anatomical disease of sequestrum, biofilm, dead space, instability and inadequate soft-tissue cover; antibiotics alone rarely correct all five.
  • A draining sinus communicating with bone strongly supports infection, but a superficial sinus swab usually reflects colonisers and should not select definitive therapy.
  • If septic, take blood cultures and start parenteral treatment immediately. If stable, avoid empirical antibiotics and preserve deep-sample yield for a planned bone-infection pathway.
  • Define previous injuries, implants, organisms, antibiotics, operations, union, perfusion, smoking, diabetes and every change in the sinus before choosing tests or surgery.
  • Initial radiographs assess sequestrum, involucrum, cloaca, deformity, fracture, non-union and implants; MRI maps marrow and soft tissue, while CT better defines cortical sequestra for planning.
  • Definitive sampling comes from multiple separately instrumented deep bone or interface specimens with histology, not a superficial swab; coordinate any tumour concern with biopsy planning.
  • Curative surgery removes infected and non-viable tissue, restores stability, manages dead space and provides vascularised cover, followed by culture-directed antimicrobials and rehabilitation.
  • Inspect a long-standing sinus for bleeding, everted edges, fungation or mass at every review because malignant transformation may present as a change in an otherwise familiar wound.

Key red flags

Fever, hypotension, spreading erythema, escalating deep pain or abrupt cessation of drainage with swelling suggests acute-on-chronic abscess or sepsis and needs urgent source-control assessment.

New deformity, mechanical pain, abnormal mobility or inability to load raises concern for infected non-union or pathological fracture and requires protection and urgent imaging.

A sinus that bleeds, enlarges, becomes everted or fungating, develops a mass or changes after years of drainage requires urgent biopsy planning for squamous carcinoma.

Coldness, pulse change, new motor or sensory deficit, or extensive soft-tissue loss demands immediate vascular, nerve and reconstructive assessment alongside infection care.

Investigation priorities

01
Initial plain radiographsFirst step

Assess chronic bone architecture, union and implant status.

Management branches

FlareRescue systemic and structural threats

Sepsis, spreading infection, abscess, neurovascular compromise or threatened fracture complicates chronic disease.

  1. Stabilise physiology, obtain blood cultures and start immediate parenteral therapy when septic.
  2. Protect an unstable bone segment and obtain urgent radiographs and source-focused cross-sectional imaging.
  3. Drain pus and remove immediately life-threatening necrosis while preserving multiple deep cultures and histology where possible.
  4. Escalate new sinus mass or bleeding through sarcoma or skin-cancer pathways rather than routine wound excision.
StableBuild the eradication plan before antibiotics

Chronic pain, sinus or infected non-union is present without systemic instability.

  1. Withhold empirical antibiotics and discuss a safe minimum two-week antibiotic-free period in non-acute infection with microbiology.
  2. Define host, perfusion, union, implants, soft tissue and disease extent with radiographs and targeted MRI or CT.
  3. Plan orthopaedic, plastic, infection, radiology and rehabilitation input in the bone-infection multidisciplinary team.
  4. At surgery obtain five deep culture samples and two histology samples before antimicrobials and irrigation.

Key medicines

Post-sampling empirical antimicrobial therapyAfter five deep cultures and histology are obtained, give the full adult regimen in the trust's chronic bone-infection protocol, then review with preliminary results at 48 hours and replace it with an organism-, surgery- and organ-function-specific prescription.Do not start empirically in a stable unsampled sinus; record allergy, renal and hepatic function, prior resistance, QT risk and interactions, and do not use prolonged therapy as a substitute for sequestrum removal, stability or cover.
Rifampicin-containing therapy when specifically selectedUse only as one component of an infection-specialist regimen for a proven susceptible staphylococcal infection with retained implant or biofilm relevance, after adequate debridement and wound control; never prescribe rifampicin alone.Check warfarin, direct oral anticoagulants, hormonal contraception, antiepileptics and all other interactions, liver function and resistance risk; a persistently draining wound or rifampicin monotherapy promotes failure.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BOASt - Fracture Related Infections
  • NICE CKS Osteomyelitis
  • NHS Osteomyelitis
  • Diagnosing fracture-related infection: current concepts and recommendations
  • Marjolin's ulcer in chronic wounds - review of available literature

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom